Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion type Assertion NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_head.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion description "[The patient was treated with an HD-CAV chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, ifosfamide, etoposide) and was free of tumor until 18 months later, at which time he developed multiple metastases in the lungs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_provenance.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion evidence source_evidence_literature NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_provenance.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion SIO_000772 10555010 NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_provenance.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion wasDerivedFrom befree-20150227 NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_provenance.
- NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_assertion wasGeneratedBy ECO_0000203 NP284300.RAU3U-dt3PH9Hy2RCZ7ohB7KcJ4OxGm34eckLyn0gA3pE130_provenance.